Categories: aggregated

The Trillion-Dollar Question: Why Big Pharma’s Monopoly Fights to Keep Cannabis Illegal?

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma’s products.

Jason

Share
Published by
Jason

Recent Posts

From Pelvic Pain to Pleasure: The Case for Cannabis as Women’s Medicine.

From endometriosis pain to orgasmic difficulty, emerging research is pushing women’s health conditions into the…

1 hour ago

Your Second Amendment Rights Are Now Safer Than Your Weed

The Court ruled that the federal government cannot restrict gun ownership based solely on the…

1 hour ago

Texas Built a Weed Market Without Legalizing Weed

Texas still prohibits adult-use marijuana, but hemp legalization, a restricted medical program, and uneven enforcement…

1 day ago

Ganja, Faith, and the Law: Rastafari Cannabis Policies Across the Globe, Explained

Rastafari communities helped shape the modern cultural and spiritual understanding of cannabis, yet legal recognition…

1 day ago

Meet the daddy of Granddaddy Purple

Granddaddy Purple is a living legend. Personally, it was the strain that defined my transition…

1 day ago

Five photoperiod Fast Buds strains built for resin, terpenes, and yield

Fast Buds built its photoperiod collection around the traits modern growers value most: resin production,…

1 day ago